Keyphrases
Derived Peptide
100%
Proliferating Cell nuclear Antigen
100%
NKp44
100%
Tumor Cell Death
100%
Tumor Cells
18%
Tumor Growth
18%
Cell-penetrating Peptide
18%
Cell Viability
9%
Overexpression
9%
In Vivo Model
9%
Cell Death
9%
Cancer Types
9%
Apoptosis
9%
Binding Site
9%
Reduced Cell
9%
Cancer Cell Lines
9%
Cell Cycle Control
9%
Repair Cell
9%
Virulence
9%
Peptide-based
9%
DNA Replication
9%
Inhibit Tumor
9%
Anticancer Therapy
9%
Membrane-associated
9%
Tumor-bearing Mice
9%
Linear Peptide
9%
Innate Immune Receptors
9%
B16 Melanoma
9%
Hub Protein
9%
Antigen-binding Site
9%
Antigen Interaction
9%
4T1 Breast Cancer
9%
Medicine and Dentistry
Cell Death
100%
Tumor Cell
100%
Proliferating Cell Nuclear Antigen
100%
Tumor Progression
18%
Cell Penetrating Peptide
18%
Neoplasm
9%
Malignant Neoplasm
9%
Binding Site
9%
Cell Viability
9%
Programmed Cell Death
9%
Breast Cancer
9%
Cancer Cell Line
9%
Cancer Treatment
9%
Cancer Types
9%
Cell Cycle Regulation
9%
DNA Replication
9%
Melanoma B16
9%
Antibody Combining Site
9%
Immune System Receptors
9%
Immunology and Microbiology
Tumor Cell
100%
Cell Death
100%
Cycline
100%
Mouse
9%
Cell Viability
9%
Binding Site
9%
Cancer Cell Line
9%
DNA Replication
9%
NCR2
9%
Cell Cycle Regulation
9%
Paratope
9%
Immune Receptor
9%